The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial

NCT01438723 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Ischemic Heart Disease

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

Radboud University Medical Center